HCA Healthcare (HCA) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
HCA Healthcare (HCA) quarterly earnings & revenue
HCA Healthcare (HCA) reported revenue of $19.11B for Q1 2026, up 4.3% year-over-year, with net income of $1.62B and diluted EPS of $7.15.
Over the last four reported quarters, HCA Healthcare generated $76.39B in revenue and $6.79B in net income.
HCA Healthcare's next earnings report is scheduled for July 24, 2026; analysts estimate EPS of $7.10.
HCA Healthcare quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $19.11B | +4.3% | $1.62B | $7.15 |
| Q4 2025 | $19.51B | +6.7% | $1.88B | $8.14 |
| Q3 2025 | $19.16B | +9.6% | $1.64B | $6.96 |
| Q2 2025 | $18.61B | +6.4% | $1.65B | $6.83 |
| Q1 2025 | $18.32B | +5.7% | $1.61B | $6.45 |
| Q4 2024 | $18.29B | +5.7% | $1.44B | $5.63 |
| Q3 2024 | $17.49B | +7.9% | $1.27B | $4.89 |
| Q2 2024 | $17.49B | +10.3% | $1.46B | $5.53 |
HCA Healthcare (HCA) — frequently asked questions
When does HCA Healthcare (HCA) report earnings next?
HCA Healthcare is expected to report earnings on July 24, 2026. Analysts estimate EPS of $7.10.
What was HCA's revenue last quarter?
HCA Healthcare reported revenue of $19.11B in Q1 2026, up 4.3% from the same quarter a year earlier.
What was HCA's EPS last quarter?
HCA Healthcare reported diluted EPS of $7.15 in Q1 2026.
Is HCA Healthcare profitable?
HCA Healthcare is currently profitable, with $6.79B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)